Connection
Christina Chambers to United States Food and Drug Administration
This is a "connection" page, showing publications Christina Chambers has written about United States Food and Drug Administration.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.307 |
|
|
|
-
Schatz M, Krishnan JA, Chambers C. Implications of Changes in U.S. Food and Drug Administration Prescribing Information Regarding the Safety and Use of Asthma Biologics during Pregnancy. Ann Am Thorac Soc. 2018 10; 15(10):1131-1136.
Score: 0.131
-
Mahadevan U, McConnell RA, Chambers CD. Drug Safety and Risk of Adverse Outcomes for Pregnant Patients With Inflammatory Bowel Disease. Gastroenterology. 2017 02; 152(2):451-462.e2.
Score: 0.114
-
Namazy J, Chambers C, Sahin L, Johnson T, Dinatale M, Lappin B, Schatz M. Clinicians' Perspective of the New Pregnancy and Lactation Labeling Rule (PLLR): Results from an AAAAI/FDA Survey. J Allergy Clin Immunol Pract. 2020 06; 8(6):1947-1952.
Score: 0.036
-
Palmsten K, Hernández-Díaz S, Chambers CD, Mogun H, Lai S, Gilmer TP, Huybrechts KF. The Most Commonly Dispensed Prescription Medications Among Pregnant Women Enrolled in the U.S. Medicaid Program. Obstet Gynecol. 2015 Sep; 126(3):465-473.
Score: 0.026